Jill Desimone - Net Worth and Insider Trading
Jill Desimone Net Worth
The estimated net worth of Jill Desimone is at least $52,624 dollars as of 2024-05-03. Jill Desimone is the Director of Praxis Precision Medicines Inc and owns about 967 shares of Praxis Precision Medicines Inc (PRAX) stock worth over $52,624. Details can be seen in Jill Desimone's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jill Desimone has not made any transactions after 2023-10-05 and currently still holds the listed stock(s).
Transaction Summary of Jill Desimone
Jill Desimone Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jill Desimone owns 3 companies in total, including Praxis Precision Medicines Inc (PRAX) , Oncternal Therapeutics Inc (ONCT) , and Kinnate Biopharma Inc (KNTE) .
Click here to see the complete history of Jill Desimone’s form 4 insider trades.
Insider Ownership Summary of Jill Desimone
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PRAX | Praxis Precision Medicines Inc | 2023-10-05 | director |
| ONCT | Oncternal Therapeutics Inc | 2023-01-04 | director |
| KNTE | Kinnate Biopharma Inc | 2023-03-01 | director |
Jill Desimone Latest Holdings Summary
Jill Desimone currently owns a total of 1 stock. Jill Desimone owns 967 shares of Praxis Precision Medicines Inc (PRAX) as of October 5, 2023, with a value of $52,624.
Latest Holdings of Jill Desimone
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PRAX | Praxis Precision Medicines Inc | 2023-10-05 | 967 | 54.42 | 52,624 |
Holding Weightings of Jill Desimone
Jill Desimone Form 4 Trading Tracker
According to the SEC Form 4 filings, Jill Desimone has made a total of 1 transactions in Praxis Precision Medicines Inc (PRAX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Praxis Precision Medicines Inc is the acquisition of 967 shares on October 5, 2023, which cost Jill Desimone around $25,375.
Insider Trading History of Jill Desimone
- 1
Jill Desimone Trading Performance
GuruFocus tracks the stock performance after each of Jill Desimone's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jill Desimone is 1.78%. GuruFocus also compares Jill Desimone's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jill Desimone within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jill Desimone's insider trading performs compared to the benchmark.
Performance of Jill Desimone
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -32.12 |  | | | | |
| Relative Return to S&P 500(%) | -34.47 | | | | | |
Jill Desimone Ownership Network
Jill Desimone Owned Company Details
What does Praxis Precision Medicines Inc do?
Who are the key executives at Praxis Precision Medicines Inc?
Jill Desimone is the director of Praxis Precision Medicines Inc. Other key executives at Praxis Precision Medicines Inc include Chief Executive Officer Marcio Souza , Chief Financial Officer Timothy Edwin Kelly , and Principal Accounting Officer Lauren Mastrocola .
Praxis Precision Medicines Inc (PRAX) Insider Trades Summary
Over the past 18 months, Jill Desimone made 1 insider transaction in Praxis Precision Medicines Inc (PRAX) with a net purchase of 14,500. Other recent insider transactions involving Praxis Precision Medicines Inc (PRAX) include a net purchase of 80,002 shares made by Marcio Souza , a net purchase of 50,000 shares made by Dean J Mitchell , and a net purchase of 8,000 shares made by Timothy Edwin Kelly .
In summary, during the past 3 months, insiders sold 0 shares of Praxis Precision Medicines Inc (PRAX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Praxis Precision Medicines Inc (PRAX) were sold and 10,167 shares were bought by its insiders, resulting in a net purchase of 10,167 shares.
Praxis Precision Medicines Inc (PRAX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Praxis Precision Medicines Inc Insider Transactions
Jill Desimone Mailing Address
Above is the net worth, insider trading, and ownership report for Jill Desimone. You might contact Jill Desimone via mailing address: C/o Praxis Precision Medicines, Inc., 99 High Street, 30th Floor, Boston Ma 02110.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
